| AmphiStar B.V.. (7/14/25). "Press Release: AmphiStar Secures €12.5m EIC Funding to Bring its Biosurfactants to Market". |
2025-07-14 |
| Coulter Partners. (7/10/25). "Press Release: Coulter Partners Continues Partnership with iOnctura and Places New Chief Financial Officer". |
2025-07-10 |
| Nuclidium AG. (7/10/25). "Press Release: Nuclidium Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform". Basel & Munich. |
2025-07-10 |
| Actithera Norway AS. (7/9/25). "Press Release: Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy". Oslo & Cambridge, MA. |
2025-07-09 |
| BrainEver SAS. (7/3/25). "Press Release: BrainEver Secures €33 Million in Series B Funding to Advance ALS Clinical Program". Paris. |
2025-07-03 |
| Galapagos N.V.. (6/23/25). "Press Release: Galapagos Appoints Aaron Cox as Chief Financial Officer". Mechelen. |
2025-06-23 |
| BioNTech SE. (6/12/25). "Press Release: BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer". Mainz & Tübingen. |
2025-06-12 |
| SpliceBio S.L.. (6/11/25). "Press Release: SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines". Barcelona. |
2025-06-11 |
| Uniqure N.V.. (6/11/25). "Press Release: Uniqure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer". Lexington, MA & Amsterdam. |
2025-06-11 |
| Mosanna Therapeutics, Inc.. (6/9/25). "Press Release: Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea". Redwood City, CA. |
2025-06-09 |
| Atai Life Sciences N.V.. (6/2/25). "Press Release: Atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies". New York, NY, Berlin & Oxford. |
2025-06-02 |
| VectorY Therapeutics B.V.. (5/27/25). "Press Release: VectorY Therapeutics Appoints Jessica Atkinson as Chief Business Officer". Amsterdam & Boston, MA. |
2025-05-27 |
| Qiagen N.V.. (5/22/25). "Press Release: Qiagen Expands Digital PCR Oncology Research Portfolio through Partnership with ID Solutions". Venlo. |
2025-05-22 |
| Augustine Therapeutics N.V.. (5/21/25). "Press Release: Augustine Therapeutics Appoints Rie Schultz Hansen, PhD, as Chief Scientific Officer and Establishes Copenhagen-based Subsidiary". Leuven. |
2025-05-21 |
| ReproNovo SA. (5/21/25). "Press Release: ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health". Lausanne & Copenhagen. |
2025-05-21 |
| Galapagos N.V.. (5/13/25). "Press Release: Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes". Mechelen. |
2025-05-13 |
| Azafaros B.V.. (5/13/25). "Press Release: Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders". Leiden. |
2025-05-13 |
| Qiagen N.V.. (5/12/25). "Press Release: Qiagen Enhances Leading Clinical Genomics Portfolio with Acquisition of Genoox AI-powered Software". |
2025-05-12 |
| Quidditas S.A.. (5/11/25). "Press Release: Quidditas Raises €2.62M to Accelerate Development of Pioneering Genome Editing Technology". Liège. |
2025-05-12 |
| Augustine Therapeutics N.V.. (4/30/25). "Press Release: Augustine Therapeutics Builds Its Management Team with Virginie Cartage Joining as CFO and Dr. Andy Hu as CBO". Leuven. |
2025-04-30 |
| Granite Bio AG. (4/24/25). "Press Release: Granite Bio Debuts with $100 Million of Capital". Basel & San Francisco, CA. |
2025-04-24 |
| Tessellate Bio B.V.. (4/23/25). "Press Release: Boehringer Ingelheim and Tessellate Bio Partner to Develop First-in-class Precision Treatments for People with Hard-to-treat Cancers". Ingelheim & Amsterdam. |
2025-04-23 |
| Qiagen N.V.. (4/22/25). "Press Release: Qiagen Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025". Venlo. |
2025-04-22 |
| Galapagos N.V.. (4/21/25). "Press Release: Galapagos Announces Executive Leadership Updates". Mechelen. |
2025-04-21 |
| AMT Medical B.V.. (4/17/25). "Press Release: AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery". Ede / Utrecht. |
2025-04-17 |
| AATec Medical GmbH. (4/15/25). "Press Release: AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development". Munich. |
2025-04-15 |
| Galapagos N.V.. (4/15/25). "Press Release: Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025". Mechelen. |
2025-04-15 |
| Inbiome B.V.. (4/11/25). "Press Release: Inbiome Shatters Diagnostic Delays – IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals". Amsterdam. |
2025-04-11 |
| Augustine Therapeutics N.V.. (4/9/25). "Press Release: Augustine Therapeutics Appoints Industry Veteran Pascale Witz as Chair of its Board of Directors". Leuven. |
2025-04-09 |
| Tecan Group Ltd.. (4/8/25). "Press Release: IBL International Collaborates with Grifols on Advanced Biomarker Panels". Männedorf. |
2025-04-08 |
| Neurona Therapeutics. (4/3/25). "Press Release: Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline". South San Francisco, CA. |
2025-04-03 |
| Novadip Biosciences S.A.. (4/2/25). "Press Release: Novadip Appoints Soumya Chandramouli as Chief Financial Officer". Mont-Saint-Guibert. |
2025-04-02 |
| Coulter Partners. (4/1/25). "Press Release: Coulter Partners Announces Promotion of Penny Sadler to Managing Partner". |
2025-04-01 |
| Navigo Proteins GmbH. (4/1/25). "Press Release: Navigo Proteins Announces Strategic R&D Collaboration with SCK CEN to Develop Targeted Radiotheranostics". Halle (Saale) & Mol. |
2025-04-01 |
| AIRNA Corporation. (4/1/25). "Press Release: AIRNA Raises Oversubscribed $155 Million Series B Financing to Fund Phase 1/2 Clinical Trial for Alpha-1 Antitrypsin Deficiency and Future Pipeline". Cambridge, MA & Tübingen. |
2025-04-01 |
| Augustine Therapeutics N.V.. (3/24/25). "Press Release: Augustine Therapeutics Raises Oversubscribed EUR 78 Million / USD 85 Million Series A Financing Round". Leuven. |
2025-03-24 |
| Byondis B.V.. (3/24/25). "Press Release: Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer". Nijmegen. |
2025-03-24 |
| Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners Exceeds Target with €165M Biotech Acceleration Fund, Europe’s Largest, with Strong Pharma Support". Paris. |
2025-03-18 |
| [iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. |
2025-03-18 |
| EsoBiotec SA. (3/17/25). "Press Release: EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition". Mont-Saint-Guibert. |
2025-03-17 |
| Centogene N.V.. (3/12/25). "Press Release: Centogene Closes Strategic Transaction with Private Equity Group Charme Capital Partners". Cambridge, MA, Rostock & Berlin. |
2025-03-12 |
| Agomab Therapeutics N.V.. (3/10/25). "Press Release: Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease". Antwerp. |
2025-03-10 |
| Trimtech Therapeutics Ltd.. (3/5/25). "Press Release: Trimtech Therapeutics Raises $31M Seed Funding to Advance Targeted Protein Degradation Pipeline for Treatment of Neurodegenerative Diseases". Cambridge. |
2025-03-05 |
| Corden Pharma International GmbH. (3/5/25). "Press Release: CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland". Basel. |
2025-03-05 |
| Forbion Capital Partners. (3/3/25). "Press Release: Forbion Expands US Presence with the Appointment of Regina Salvat, PhD, as Principal in the Boston Office". Naarden. |
2025-03-03 |
| Qiagen N.V.. (3/3/25). "Press Release: Qiagen Takes Legal Action to Defend QuantiFERON Intellectual Property and Protect Innovations in Latent Tuberculosis Testing". Venlo. |
2025-03-03 |
| FoRx Therapeutics AG. (2/26/25). "Press Release: FoRx Therapeutics Appoints Chief Medical Officer and Provides an Update on Its Lead Development Candidate". Basel. |
2025-02-26 |
| Kintiga (MAP Patient Access Ltd.). (2/26/25). "Press Release: Kintiga to Be Officially Launched at the World EPA Congress in Amsterdam, 5-6 March 2025". Cambridge. |
2025-02-26 |
| VarmX B.V.. (2/25/25). "Press Release: VarmX Awarded €15 Mln Follow-on Equity Investment by the EIC Accelerator". Leiden. |
2025-02-25 |
| Ion Opticks Pty Ltd.. (2/24/25). "Press Release: IonOpticks Announces Strategic Global Expansion with Key Leadership Appointments". Melbourne. |
2025-02-24 |
| Atai Life Sciences AG. (2/20/25). "Press Release: Atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares". New York, NY & Berlin. |
2025-02-20 |
| Ginkgo Bioworks Inc.. (2/20/25). "Press Release: Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care". Boston, MA. |
2025-02-20 |
| Vivalyx GmbH. (2/19/25). "Press Release: Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology". Aachen. |
2025-02-19 |
| Qiagen N.V.. (2/13/25). "Press Release: Qiagen Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region". Venlo & Redwood City, CA. |
2025-02-13 |
| Augustine Therapeutics N.V.. (2/13/25). "Press Release: Augustine Therapeutics Appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic". Leuven. |
2025-02-13 |
| AIRNA Corporation. (1/30/25). "Press Release: AIRNA Appoints Matthew Hawryluk as Chief Business Officer". Cambridge, MA & Tübingen. |
2025-01-30 |
| TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
| Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
| Kintiga (MAP Patient Access Ltd.). (1/27/25). "Press Release: The MAP Group Unites Three Companies Under One New Brand Name, Kintiga". Cambridge. |
2025-01-27 |
| Pharming Group N.V.. (1/21/25). "Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer". Leiden. |
2025-01-21 |
| European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products". |
2025-01-14 |
| Forbion Capital Partners. (1/13/25). "Press Release: Forbion Promotes Dirk Kersten to Managing Partner and Strengthens US Team". Naarden. |
2025-01-13 |
| RhyGaze AG. (1/10/25). "Press Release: Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration". Basel & Philadelphia, PA. |
2025-01-10 |
| CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
| Boehringer Ingelheim. (1/9/25). "Press Release: Boehringer Ingelheim Broadens Oncology Portfolio with License for Synaffix’s ADC Technology". Amsterdam, Basel & Ingelheim. |
2025-01-09 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| BioLizard N.V.. (1/9/25). "Press Release: BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco". Ghent. |
2025-01-09 |
| EsoBiotec SA. (1/8/24). "Press Release: EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2025-01-08 |
| Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden. |
2025-01-08 |
| Qiagen N.V.. (1/7/25). "Press Release: Qiagen Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content". Redwood City, CA & Venlo. |
2025-01-07 |
| Merck KGaA. (1/6/25). "Press Release: Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio". Darmstadt. |
2025-01-06 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt. |
2024-12-17 |
| Evaxion Biotech A/S. (12/17/24). "Press Release: Evaxion Pursues Agreement with EIB to Bolster Equity through Conversion of Debt into Equity". Copenhagen. |
2024-12-17 |
| VectorY Therapeutics B.V.. (12/16/24). "Press Release: VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO". Amsterdam & Boston, MA. |
2024-12-16 |
| Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
| Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
| Pharming Group N.V.. (12/15/24). "Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB". Leiden. |
2024-12-15 |
| Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
| Kadans Science Partner. (12/12/24). "Press Release: Kadans Science Partner with the Support of Accumulata to Transform Former Signa Property into Life Science Innovation Hub". Berlin. |
2024-12-12 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London. |
2024-12-11 |
| EsoBiotec SA. (12/11/24). "Press Release: EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2024-12-11 |
| Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
| Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven. |
2024-12-04 |
| TME Pharma N.V.. (12/4/24). "Press Release: (CORRECTING and REPLACING) TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of T |
2024-12-04 |
| Mainz Biomed N.V.. (11/29/24). "Press Release: Mainz Biomed Announces Stock Split". Berkeley, CA & Mainz. |
2024-11-29 |
| Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Agomab Therapeutics N.V.. (11/18/24). "Press Release: Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors". Antwerp. |
2024-11-18 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
| VarmX B.V.. (11/12/24). "Press Release: VarmX Announces Appointment of John Glasspool as CEO". Leiden. |
2024-11-12 |
| Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
| Tessellate Bio B.V.. (11/4/24). "Press Release: Tessellate Bio Announces Appointment of Lara Boyd as Chief Business Officer". Amsterdam & Stevenage. |
2024-11-04 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
